AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $857,550 | +0.5% | 12,270 | +3.4% | 0.00% | 0.0% |
Q2 2023 | $852,978 | +2.2% | 11,870 | -12.2% | 0.00% | 0.0% |
Q1 2023 | $834,222 | +15.7% | 13,525 | +44.7% | 0.00% | 0.0% |
Q4 2022 | $721,166 | +49.9% | 9,350 | -13.3% | 0.00% | +50.0% |
Q3 2022 | $481,000 | -25.7% | 10,790 | -36.1% | 0.00% | -33.3% |
Q2 2022 | $647,000 | +2.9% | 16,890 | +11.2% | 0.00% | +50.0% |
Q1 2022 | $629,000 | +3.5% | 15,187 | -5.6% | 0.00% | 0.0% |
Q4 2021 | $608,000 | -0.7% | 16,087 | -13.4% | 0.00% | 0.0% |
Q3 2021 | $612,000 | +6.4% | 18,577 | +117.9% | 0.00% | 0.0% |
Q2 2021 | $575,000 | +18.1% | 8,527 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $487,000 | -63.2% | 8,607 | -47.1% | 0.00% | -60.0% |
Q4 2020 | $1,325,000 | +31.1% | 16,267 | +14.6% | 0.01% | +25.0% |
Q3 2020 | $1,011,000 | -12.7% | 14,192 | +0.9% | 0.00% | -33.3% |
Q2 2020 | $1,158,000 | +205.5% | 14,072 | +118.5% | 0.01% | +200.0% |
Q1 2020 | $379,000 | -79.3% | 6,440 | -63.7% | 0.00% | -77.8% |
Q4 2019 | $1,833,000 | – | 17,732 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |